By Stephen Nakrosis
Cannabis company InterCure said Monday its board has approved a voluntary delisting of shares from the Toronto Stock Exchange.
The company, which does business as Canndoc, said its shares will continue to trade on the Nasdaq and the Tel Aviv Stock Exchange.
"After a careful review of the trading volume data relating to the shares, the board has concluded that the trading volume on the TSX in insufficient to justify the continued listing, InterCure said.
InterCure said it will remain a "'reporting issuer' under applicable Canadian securities laws."
The company said it applied to delist its shares from the Toronto exchange at the end of the August 14 trading session.
Write to Stephen Nakrosis at stephen.nakrosis@wsj.com
"exchange" - Google News
July 11, 2023 at 04:19AM
https://ift.tt/3LMFqB8
InterCure Plans to Delist From Toronto Stock Exchange - MarketWatch
"exchange" - Google News
https://ift.tt/nFSYzLH
https://ift.tt/mpLBrHV
Exchange
Bagikan Berita Ini
0 Response to "InterCure Plans to Delist From Toronto Stock Exchange - MarketWatch"
Post a Comment